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Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality and it is responsible for an increasing
resource burden. The identification of patients at high risk for adverse events is crucial to select those who will receive the greatest
benefit from revascularization. To this aim, several non-invasive functional imaging modalities are usually used as gatekeeper to
invasive coronary angiography, but the diagnostic yield of elective invasive coronary angiography remains unfortunately low. Stress
myocardial perfusion imaging by cardiac magnetic resonance (stress-CMR) has emerged as an accurate technique for diagnosis
and prognostic stratification of the patients with known or suspected CAD thanks to high spatial and temporal resolution, absence
of ionizing radiation, and the multiparametric value including the assessment of cardiac anatomy, function, and viability. On the
other side, cardiac computed tomography (CCT) has emerged as unique technique providing coronary arteries anatomy and more
recently, due to the introduction of stress-CCT and noninvasive fractional flow reserve (FFR-CT), functional relevance of CAD
in a single shot scan. The current review evaluates the technical aspects and clinical experience of stress-CMR and CCT in the
evaluation of functional relevance of CAD discussing the strength and weakness of each approach.
1. Introduction
Coronary artery disease (CAD) is a major cause of mortality
and morbidity in the western countries and its increasing
prevalence is responsible for advances in percutaneous and
surgical revascularization [1]. The related cost of revascular-
ization procedures has resulted in a great interest of health-
care community regarding appropriateness of this technique
and how to select the patients with known or suspected CAD
who will receive the greatest benefits from these invasive
treatments. Indeed, inappropriate revascularizationmay gen-
erate costs to the healthcare system while appropriate revas-
cularization improves patients’ outcome [1]. For this reason,
guidelines recommend different diagnostic strategy based on
the pretest likelihood of CAD and suggest a conservative
observational approach in the case of patients with a very
low risk, non-invasive stress testing to detect ischemic burden
as gatekeeper to invasive coronary angiography (ICA) in
intermediate risk patients, and direct referral for ICA in high-
risk patients for CAD. The intermediate risk patients are the
most representative population referred to clinical evaluation
for suspected or known CAD and the use of imaging tests in
this setting has doubled from 2000 to 2006 with $ 14.1 billion
in Medicare budget in 2006. Several non-invasive imaging
modalities such as exercise electrocardiogram (ECG), stress
echocardiography, or nuclear stress tests are suggested as
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gatekeeper to ICA [1]. However, the diagnostic yield of
elective ICA remains low. Patel et al. [2] have showed in
a US national register that the prevalence of obstructive
coronary artery stenoses in 398978 consecutive patients
referred to ICA for suspected CAD was only 38%. The low
diagnostic yield of elective ICA occurs despite the fact that
84% of study population undergoing ICA had performed a
previous non-invasive diagnostic test. It has also emerged
that although non-invasive test was independently related
to the presence of obstructive CAD, the additional value
of a positive non-invasive stress test to predict obstructive
CAD beyond the Framingham risk category and symptom
characteristics was limited [2]. However, the evaluation
of functional relevance of CAD with noninvasive tests as
gatekeeper to ICA remains mandatory. Indeed, the Clinical
Outcome Utilizing Revascularization and Aggressive Drug
Evaluation trial (COURAGE) [3] and the COURAGE trial
nuclear substudy [4] have demonstrated that the event-free
survival with coronary revascularization was greater than
optimal medical therapy in patients with ≥10% ischemic
myocardium at baseline and with a reduction of ischemic
myocardium ≥5% after treatment. Stress myocardial perfu-
sion imaging by cardiac magnetic resonance (stress-CMR)
has emerged during the past decade as accurate technique
for diagnosing and prognostic stratification of the patients
with known or suspected CAD thanks to high spatial and
temporal resolution, absence of ionizing radiation, and the
multiparametric value including the assessment of cardiac
anatomy, function, and viability [5].On the other side, cardiac
computed tomography (CCT) has emerged as unique non-
invasive technique providing coronary arteries anatomy and
more recently as competitive technique able to evaluate
the functional relevance of coronary artery stenoses in a
single shot scan by using both stress-CCT and fractional
flow reserve (FFR-CT) [6]. The current review evaluates
the technical aspects and clinical experience of stress-CMR
and CCT in the assessment of functional relevance of CAD
discussing the strength and weakness of each approach.
2. How to Evaluate Functional
Relevance of CAD
There are two different approaches to evaluate functional
relevance of CAD: the assessment of myocardial perfusion
under stress and the measurement of FFR. The rationale for
stress myocardial perfusion imaging is based on the concept
of coronary flow reserve [7] that is briefly described in
Figure 1. The cardiac metabolism is mainly aerobic and it is
sustained by a coronary blood flow of about 0.8–1mL/gr/min
that occurs in diastolic phase and it is driven by gradient
between the diastolic blood pressure and the end-diastolic left
ventricle pressure [7]. At rest condition, the autoregulation
mechanism by adjusting coronary microvascular resistance
maintains coronary blood flow constant in a wide range of
coronary perfusion gradient pressure and the heart utilizes
the maximum oxygen extraction corresponding to 80% of
the oxygen available in the blood pool. Therefore, in the
conditions in which the oxygen demand is increased, a
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Figure 1: Coronary flow reserve. Relationship between the coronary
artery gradient pressure (difference between the epicardial coronary
artery and microcirculation pressure) and coronary blood flow at
rest condition (blue line) and at maximal vasodilatation (red line).
The coronary flow reserve (CRF) is defined as the ratio between the
coronary blood flow at maximum vasodilatation and the coronary
blood flow at rest condition.
maximal coronary artery vasodilatation occurs to reach a
direct relationship between coronary artery gradient pressure
and coronary artery blood flow. The coronary artery flow
reserve (CFR) is the ratio between the coronary artery flow
at maximum vasodilatation and the coronary blood flow at
rest. Usually, in the absence of epicardial coronary artery
disease, CRF increases by factor 5 or more while in presence
of 50% epicardial coronary artery lumen reduction CRF
decreases up to be abnormal at rest in the presence of high
degree of stenoses (>85%) [8, 9]. The maximal vasodilatation
can be brought with pharmacologic stress by using three
different drug stressors such as adenosine, dipyridamole,
or regadenoson that are briefly described in Table 1. Both
adenosine and dipyridamole are direct and indirect not-
selective adenosine receptor agonists, respectively, providing
up to fourfold increase of coronary flow. In the presence
of epicardial coronary stenoses both drug stressors act on
normal vessels but have no effects on stenotic vessels pro-
ducing ischemia based on “steal phenomenon” [10]. More
recently, regadenoson, a selective A
2A receptor agonist, has
been approved for pharmacological stress test with the great
advantage of having minor side effects as compared to
adenosine and dipyridamole [11]. Of note, the myocardial
perfusion can be evaluated by dobutamine as well. How-
ever, dobutamine induces ischemia by improving heart rate
rather than “steal phenomen”.Therefore, the perfusion defect
detected by dobutamine is an indirect effect of mismatch
between the mycoradial perfusion and myocardial oxygen
consumption due to increase of heart rate. The myocardial
ischemia induced by “steal phenomenon” is the base of
perfusion and wall motion abnormalities detection during
stress-CMR and stress-CCT. Unfortunately, the CFR is an
expression of a pressure gradient between epicardial coronary
artery and microcirculation and therefore it is reduced in
case of collaterals or microcirculation disease even in the
absence of epicardial stenosis [12]. For this reason, these stress
perfusion tests are not able to distinguish between the two
entities. To this regard, the invasive FFR has been introduced
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Table 1: Summary of the most common drug stressors used for the evaluation of myocardial perfusion.
Drug stressors Action Half-life Side effects Cost
Adenosine
Coronary vasodilatation induced by not-selective
A1 adenosine-receptors stimulation (increasing
cellular cAMP levels)
10 seconds
Facial flushing
Diaphoresis nausea asthma
Bradyarrhythmias
↑↑↑
Dipyridamole
Coronary vasodilatation induced by inhibition of
the phosphodiesterase enzymes that normally
break down cAMP (increasing cellular cAMP
levels)
25 minutes
Facial flushing
Diaphoresis nausea asthma
Bradyarrhythmias
↑
Regadenoson Coronary vasodilatation induced by selective A2Aadenosine-receptors stimulation 2-3 minutes
Headache, dizziness, nausea, stomach
discomfort, decreased sense of taste, mild
chest discomfort, or warmth, redness, or
tingly feeling under your skin
↑↑
to overcome these limitations. FFR is performed by dedicated
solid-state sensor mounted on a floppy-tipped guidewire.
It measures the intracoronary pressure before and after a
specific coronary lesion in the presence of hyperaemic stimuli
by adenosine reaching a direct relationship between pressure
and flow.Therefore, FFR can be expressed as the ratio ofmax-
imum blood flow after coronary artery stenoses to maximum
blood flow. Coronary artery lesions with FFR ≤ 0.80 have
been proved to receive benefits from revascularization while,
in a setting of a stenosis with a FFR > 0.80, the patient can
be safely deferred to optimal medical treatment [13, 14]. More
important, unlike the ischemia stressors induced, FFR is not
influenced by systemic hemodynamic [15, 16], it takes into
account the contribution of collaterals [17, 18], it specifically
relates to the severity of the stenoses and to the mass of
tissue to be perfused [19], and it reaches a per-lesion accuracy
rather than per-myocardial territory with a very high spatial
resolution [12]. The main principles of FFR are described
in Figure 2. In conclusion, it is of paramount importance to
determine if a coronary stenosis is associated with reversible
ischemia for decision making of treatment, and myocardial
perfusion under stress or FFR are two sides of same coin.
2.1. Functional Relevance of CAD by CMR
2.1.1. Principles of Stress Cardiac Magnetic Resonance Pro-
tocol. Despite the fact that the technical aspects of stress-
CMR are beyond the aim of this paper, a summary of
the most common protocols used is described below and
illustrated in Figure 3 according to the recommendations
of the Society of Cardiovascular Magnetic Resonance [20].
After steady-state free precession cine acquisitions have been
acquired at rest during held expiration in multiple short
and long axes, coronary vasodilatation can be induced with
drug infusion and then first-pass perfusion technique using
saturation-preparedT1-weighted fast gradient-echo sequence
with simultaneous gadolinium contrast agent injection. In
case of use of dipyridamole as stressor, due to the longer
half-life as compared to adenosine, left ventricle kinesis
under stress can be evaluated by further steady-state free
precession cine acquisitions with the same geometry used at
rest. Theophylline is intravenously injected to null the effect
of dipyridamole at the end of stress test. Ten minutes after
contrast injection, breath-hold contrast-enhanced segmented
T1-weighted inversion-recovery gradient-echo sequences are
acquiredwith the same prescriptions for cine images to detect
late gadolinium enhancement (LGE). At the end of exam, a
further first-pass perfusion technique is performed to provide
myocardial perfusion at rest.
2.1.2. Principles of Evaluation of Reversible Ischemia. The
clinically predominant mode of reading and interpreting
myocardial perfusion studies is based on visual approach.
Beyond the usual parameters estimated by CMR such as end
diastolic and end systolic left and right ventricle volume,
left ventricle mass, and left and right ejection fraction, a
reversible perfusion defect is defined as persistent delay
of enhancement during first pass of contrast agent for >3
heartbeats after maximum signal intensity in the cavity of the
left ventricle that does not correspond to perfusion defect
at rest. Similarly, each myocardial segment is classified as
normal, hypokinetic, akinetic, or dyskinetic. Accordingly,
each stress-CMR can be classifiedas normal for reversible
ischemia (no evidence of ischemia due to the absence of
stress perfusion defect in at least 1 myocardial segment
free from LGE), positive for reversible myocardial perfusion
defect alone (evidence of stress perfusion defect in at least 1
myocardial segmentwithout corresponding LGE), or positive
for both perfusion and wall motion abnormalities (WMA)
(evidence of stress perfusion defect in at least 1 myocardial
segment without corresponding LGE plus stress WMA as
compared to rest condition). A quantitative analysis of the
myocardial perfusion is feasible as well. The epicardial and
endocardial borders of the left ventricle wall have to be
detected for each image frame of perfusion study to derive
parameters value of time course of contrast agent as showed
in Figure 4. For each curve, a time to arrival of contrast agent,
a time to peak of signal intensity, or the slope of curve can
be calculated and compared between stress and rest. Despite
the fact that the quantitative approach has been proved more
robust to discriminate between 1-vessel and 3-vessel disease, it
is extremely time consuming and therefore not generally used
in clinical practice [21]. Several artifacts can occur during
stress-CMR. Dark subendocardial rim artifacts are the most
common and may be confused with myocardial perfusion
defects. They typically appear as dark lines at the border of
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Figure 2: Fractional flow reserve. Left panel shows the relationship between coronary perfusion pressure and myocardial blood flow at
maximum hyperemic stimulation. In the absence of coronary artery stenoses, the myocardial blood flow determinated by driving pressure at
maximum vasodilatation is 100% (blue line). In case of coronary artery stenoses (right panel) determinating a hyperemic pressure gradient
of 30 mmhg (red line) the driving pressure after the stenosis and the consequential myocardial blood flow will be reduced up to 70%
corresponding to a FFR value of 0.7. Modified by Pijls et al. [18].
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Figure 3: Stress cardiac magnetic resonance protocol. A typical stress cardiac magnetic resonance protocol is described here. For the
description see throughout the paper. LGE: late gadolinium enhancement.
blood flow and myocardium. Factors that may contribute
to the production of dark rim artifacts include partial-
volume averaging, gadolinium-induced magnetic suscep-
tibility, myocardial motion, and undersampling from low
spatial resolution, either alone or in combination. Regardless
of their cause, the artifacts are mitigated by using parallel
acquisition schemes, by reaching greater SNR with 3.0-T
magnets, or by using lower concentrations of gadolinium
leading to less severe magnetic susceptibility effects. Aliasing
artifacts are common as well in first-pass perfusion imaging
especially when parallel imaging techniques are used and
they could bemitigated by selection of a sufficiently large field
of view.
2.1.3. Stress-CMR for Diagnosis of CAD. A high number
of single and multicenter studies have proved the excellent
sensitivity and specificity of stress-CMR for diagnosis of
CAD [22–25] and are briefly described in Table 2. In a
meta-analysis by Nandalur et al. [22] involving 1183 patients,
perfusion CMR had a sensitivity of 91% and a specificity of
81% and a stress-induced WMA demonstrated a sensitivity
of 83% and specificity of 86% for diagnosis of CAD in a per-
patient analysis, respectively. Moreover, several papers have
compared stress-CMR versus single photon emission com-
puted tomography (SPECT) in terms of diagnostic accuracy.
Schwitter et al. [23] compared stress-CMR versus SPECT
in 234 patients by using ICA as reference showing a better
BioMed Research International 5
Table 2: Characteristics of a selected list of studies of the diagnostic performance of stress myocardial perfusion cardiac magnetic resonance.
Author Reference 𝑁 Sensitivity Specificity
Nandalur et al. [22] Stress-CMR versus QCA (meta-analysis) 1183 91% 81%
Schwitter et al. [23] Stress-CMR and SPECT versus QCA 234 67% 85%
Greenwood et al. [24] Stress-CMR and SPECT versus QCA 752 86% 83%
Schwitter et al. [25] Stress-CMR and SPECT versus QCA 533 75% 59%
Greenwood et al. [26] Stress-CMR and SPECT versus QCA 235 88% 83%
CMR: cardiac magnetic resonance; QCA: quantitative coronary angiography; SPECT: single photon emission computed tomography.
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Figure 4: Time course of gadolinium myocardium enhancement.
The time attenuation curve within a region of interest is obtained
by fitting several sampling of myocardial signal intensity over time
during the first pass imaging. For each curve arrival time, peak time
and slope can be measured and compared between stress and rest
condition. Modified by Patel et al. [21].
performance of stress-CMRversus SPECTwith an area under
the curve (AUC) of 0.86 ± 0.06 versus 0.67 ± 0.05 (𝑃: 0.013),
respectively. It is important to note that in this study, gated-
SPECT, that is considered now the standard technique for
stress nuclear tests, was available in approximately half of
patients.Moreover, the population evaluated inMR-IMPACT
I was at high risk for CAD that is not the typical population
referred to noninvasive stress tests in clinical practice. InMR-
IMPACT II trial [25] 533 patients were enrolled in 33 centres
and evaluated by stress-CMR and gated-SPECT before ICA.
The study population was at intermediate risk of CAD as
proved by prevalence of obstructive coronary stenoses. No
differences were found between the stress-CMR and SPECT
in terms of percentage of not-evaluable tests (5.6% versus
3.7%, resp.; 𝑃: 0.21) while stress-CMR showed a higher
sensitivity score (0.67 versus 0.59, resp.; 𝑃: 0.024) but a lower
specificity score (0.61 versus 0.72, resp.;𝑃: 0.038). In the larger
multicenter trial CE-MARC [24], stress-CMR and SPECT
showed sensitivity, specificity, positive predictive value, and
negative predictive value of 86%, 83%, 77%, and 90% and
66%, 82%, 71%, and 79%, respectively. The sensitivity and
negative predictive value of stress-CMR and SPECT differed
significantly (𝑃 < 0.0001 for both) but specificity and positive
predictive value did not. Moreover, stress-CMR showed a
higher AUC as compared to SPECT (0.89 versus 0.79; 𝑃 <
0.0001) regardless of the threshold used to define the presence
of obstructive CAD (50% or 70% of coronary artery stenoses)
and regardless of the presence of one or multiple vessels
disease. Importantly, in CE-MARC trial a multiparametric
protocol has been used including wall motion at rest by
balanced steady-state free precession cine imaging, stress and
rest perfusion by T1-weighted saturation recovery, evalua-
tion of coronary artery stenoses by 3D coronary magnetic
resonance angiography, and LGE by T1-weighted segmented
inversion-recovery gradient-echo pulse sequence. A positive
stress-CMR was defined as any evidence of regional wall
motion abnormality and/or perfusion defect at stress and/or
the presence of obstructive coronary artery stenoses and/or
any scar. Of note in a gender-based subanalysis of CE-MARC
trial [26] stress-CMR has greater sensitivity than SPECT in
both genders and, unlike SPECT, there are no significant
gender differences in the diagnostic performance. In Figure 5,
a clinical case of a 62-year-old man referred to dipyridamole
stress-CMR for exertional chest pain is reported.
2.1.4. Stress-CMR for Prognostic Stratification of CAD. Over
the past several years, multiple studies have been published
regarding stress-CMR assessment of prognosis. In a recent
meta-analysis, Lipinski et al. [27] showed in 11636 patients
that the combined outcome annualized event rates were 0.8%
for negative study and 4.9% for positive study with the evi-
dence of LGE significantly associated with worse prognosis as
well. Macwar et al. [28] found an annual event rate for hard
events of 0.6%, 1.7%, and 1.5% in normal, positive for LGE,
and positive for reversible perfusion defect adenosine stress-
CMR, respectively, in 564 patients symptomatic for chest
pain without previous history of revascularization. Similarly,
Buckert et al. [29] showed a hazard ratio of 3.2 associated
with reversible perfusion defect in a larger population (1152
patients) in a long-term follow-up (4.2 years). These data
support consistent and robust prognostic stratification by
adenosine stress-CMR and it seems that this robustness
is preserved regardless of patient’s gender [30]. Regarding
dobutamine studies, Kelle et al. [31] showed that, in a large
cohort (1369 patients) evaluated with dobutamine stress-
CMR, the annual cardiac event rate of a negative stress test
was 1.1%, while the hazard ratio associated with a positive
dobutamine stress test was 3.3. Similarly, Wallace et al. [32]
found that the presence of inducible AWM is associated
with a hazard ratio of 2.7 for future hard cardiac events
in 221 consecutive women. Only few studies have tested
the usefulness of dipyridamole stress-CMR for predicting
spontaneous clinical events [33, 34]. Bodi et al. [33] found
that the prognostic value of perfusion deficit was weaker
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Figure 5: Clinical case. Dipyridamole stress-CMR in a 62-year-old man with familiar history of CAD and hypertension, referred to chest
pain. Cine images at rest (Panel (a)) showed akinesis of anterior interventricular septum (arrow). Under stress, first pass perfusion images
showed a large perfusion defect in anterior wall of left ventricle (Panel (b), arrow) without matched wall motion abnormalities (Panel (c),
arrow). Late gadolinium enhancement images show an unknown transmuralmyocardial infarction of anterior interventricular septum (Panel
(d), arrow).
than AWM under stress suggesting that kinesis evaluation
is desirable beyond the perfusion. The latter point was
evaluated in a following paper from the same authors [34]
in 601 consecutive patients with a mean follow-up of 640
days with an annual hard event rate of 2.9%, 11.7%, and
14.1% in the three categories described above, respectively.
This progressive increase of hard event rate in these three
categories finds an explanation in the evidence that the extent
of the perfusion defect is larger in patients with concomitant
AWM [34, 35].
2.1.5. Future Perspectives. Three main fields of investigation
are developing in the detection of CAD by CMR. First, whole
heart stress-CMR perfusion techniques have been developed
in order to permit quantification of ischemic tissue volume
[36]. This approach proved to be highly diagnostic for the
detection of CAD based on invasive FFR, showing similar
sensitivity but improved specificity (90 versus 92% and 82
versus 74%, resp.) as compared to previously published data.
Jogiya et al. [37] demonstrated that whole heart myocardial
perfusion CMR accurately detects functionally significant
coronary artery disease highlighting the concept that diag-
nostic accuracywas equally high in patientswith single-vessel
and multivessel coronary artery disease and that the amount
of myocardial ischemic burden gradually increased with
more proximal anatomical localization of coronary lesions.
This method may be considered a noninvasive approach to
stratify patients before coronary angiography to identify that
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cut-off of 10% of myocardial ischemic burden that is actually
accepted as threshold for indication of interventional revas-
cularization. Second, the “blood oxygen level-dependent”
(BOLD) stress-CMR [38] has become a promising inves-
tigative method. The rationale of this promising method is
that oxyhemoglobin is slightly diamagnetic and deoxyhe-
moglobin paramagnetic resulting in the loss of T2∗ and T2
signal. Therefore, BOLD CMR uses an endogenous contrast
without additional use of an exogenous contrast. Using a
T2-prepared steady-state free precession, BOLD stress-CMR
sequences can be used to image changes of myocardial
oxygenation induced by drug stressors as an indicator of
myocardial ischemia. Myocardial perfusion assessed by the
change in myocardial oxygenation with those new sequences
has been correlated with quantitative coronary angiography
and later with fractional flow reserve to better characterize
the clinical significance of coronary stenosis [38]. Third
future perspective is to visualize the atherosclerotic plaque of
coronary arteries. Early reports demonstrated the principal
feasibility of the contrast enhancement magnetic resonance
coronary angiography (CEMRA) to visualize the coronary
artery stenoses noninvasively showing some limitations both
in sensitivity and in specificity as compared to ICA [39, 40].
A new family of contrast agents that may play an important
role in investigating molecular and cellular targets associated
with atherosclerotic plaque development has been recently
shown [41, 42]. A prospective multicenter trial [43] evaluated
the diagnostic ability of navigator-corrected SSFP whole-
heart MRCA sequences to detect significant coronary artery
stenosis (≥50% reduction in diameter) with ultrasmall super-
paramagnetic iron oxide nanoparticles showing a sensitivity
and a specificity of 88% and 72% with a negative predictive
value of 88% in a patient-based analysis as compared to ICA.
2.2. Functional Relevance of CAD by CCT. The advancement
of CCT has enabled the noninvasive evaluation of coronary
artery stenosis in several clinical scenarios [44–48] with a low
radiation exposure [49–51]. Despite high negative predictive
value, factors such as high heart rate, arrhythmia, obesity,
and high coronary calcium burden continue to limit the
overall evaluability and positive predictive value of CCT
[52, 53]. Moreover, obstructive CAD identified by CCT is
not a robust predictor of functional relevance of stenoses
[54]. So, the combination of overestimation of CAD and the
absence of functional information could be responsible for
a false positive rate up to 35% of patients that is common
event in experienced centers [55].Thus, a combined anatomic
and functional assessment of CAD is desirable to improve
the yield of ICA [56]. This aim can be reached by stress-
CCT and FFR-CT. In this section, we will briefly summarize
the technical bases and preliminary clinical findings of these
emerging novel techniques.
2.2.1. Perfusion Stress Cardiac Computed Tomography. Inves-
tigation in the field of stress-CCT started 2 decades ago
[57, 58]. Unfortunately, the clinical use of this technique
has remained restricted due to several technical limitations
such as the limited temporal resolution, spatial and contrast
resolution, and the 𝑧-axis coverage. Indeed, during a stress-
CCT, the contrast agent arrives to myocardial wall and it
attenuates X-ray based on its concentration. Thus, area with
perfusion defect is simply detectable as region with hypoat-
tenuation. However, the highest concentration of iodine
in the myocardium is reached in 1 minute after injection
with a very fast washout [59]. To imagine this very rapid
phenomenon, a high temporal resolution ismandatory. Some
strategies have been used to improve temporal resolution of
CCT [60]. The first strategy is to increase gantry rotation
time. Indeed, in order to accurately reconstruct an image, the
projection data are acquired within an angular range of 180∘
plus a 60∘ fan angle with a minimal data acquisition angular
range of 240∘. This fact determines that the typical temporal
resolution of CCT is about 50–60% of the gantry rotation
time [61]. Accordingly, the highest maximum temporal res-
olution achievable for single source scanner is 135msec that
is far from the desirable temporal resolution reached by
ICA that is around 20–30msec. The introduction of dual
source CT (DSCT) has partially overcome this limitation.
This system combines 2 arrays consisting of 1 tube and 1
detector each, arranged within the same gantry at a 90∘
offset, so that one-quarter rotation is sufficient to sample
X-ray transmission data over 180∘ of projections. With a
gantry rotation time of 330ms, the system could achieve a
temporal resolution of 83ms that is significantly higher than
single source CCT [62]. More recently, intracycle motion
correction algorithm that allows a compensation of coronary
motion by using multiphasic analysis of coronary arteries
within a single cardiac cycle has been developed for single
source scanner reaching a temporal resolution of 25msec
[63, 64]. However, a high temporal resolution needs to be
matched with a very fast scan time. There are two strategies
to improve the scan time: a higher craniocaudal coverage
by increasing the number of slices or a higher pitch or the
combination of the two strategies. Craniocaudal coverage
of 64-slice CCT coronary angiography is typically less than
40mm, giving limited coverage width. The development of
wide area detector CCT [65] enabled greater coverage per
gantry rotation and the extension from 64-slice MDCT to
256-detector row or 320-detector row system has enabled
whole heart coverage. The 256-CCT has 912 (transverse)
× 256 (craniocaudal) elements, each approximately 0.5 ×
0.5mm at the center of rotation with craniocaudal coverage
of 128mm per rotation. The 320-CCT system uses a detector
element consisting of 320 × 0.5mm detector and provides
160mmof coverage in the 𝑧-direction [66].The scan time can
be reduced by increasing the pitch, as well. In 2008, a high
pitch scanner has been introduced. It rotates with a gantry
rotation time of 280 milliseconds, a wider detector with a
pitch up to 3.2 that allows an overall scan time of about 0.27
seconds to cover the entire heart. This scan mode, known as
“Flash CT,” enables complete image acquisition within one
cardiac cycle so that theX-ray tube anddetector rotate around
the patient without overlap and with very short scan time
[67]. After temporal resolution, a second challenge in stress-
CCT is to improve the spatial and contrast resolution in the
myocardial wall. Indeed, the difference in terms of contrast
attenuation between normal and hypoperfused myocardial
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Table 3: Characteristics of a selected list of studies of the diagnostic performance of stress myocardial perfusion cardiac computed
tomography imaging.
Author Reference 𝑁 Effective radiationdose (mSv) Sensitivity Specificity
George et al. [73] Stress-CCT versus QCA + SPECT 27 16.8 86% 92%
Blankstein et al. [74] Stress-CCT and SPECT versus QCA 33 12.7 92% 67%
Rocha-Filho et al. [75] Stress-CCT versus QCA 34 11.8 96% 100%
Cury et al. [77] Stress-CCT and SPECT versus QCA 36 14.7 94% 75%
Ho et al. [78] Stress-CCT versus QCA + SPECT 35 18.2 95% 65%
Bamberg et al. [81] Stress-CCT versus invasive FFR 33 13.1 95% 64%
Feutchtner et al. [82] Stress-CCT versus stress-CMR 30 2.5 96% 88%
CCT: cardiac computed tomography; CMR: cardiac magnetic resonance; FFR: fractional flow reserve; QCA: quantitative coronary angiography; SPECT: single
photon emission computed tomography.
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Figure 6: Scan protocol of stress cardiac computed tomography.
regions ranges in the order of 50HU [68]. To highlight the
small differences in contrast attenuation between normal and
hypoperfused myocardium, it is suggested to use low tube
voltage (100KVp) to increase the photoelectric effect and to
decrease the Compton scattering associated with low tube
voltage [69]. However, the low tube voltage increases the
image noise and the use of adaptive iterative reconstruction
algorithm rather than the filtered back projection algorithm
is recommended to limit the image noise increase when
low tube voltage is employed [50]. Despite the use of low
tube voltage and iterative reconstruction algorithm, the beam
hardening artefacts continue to be an issue of concern during
a stress-CCT because they can mimic a false perfusion
defect. These artifacts are due to the polychromatic nature
of X-rays and the energy dependency of X-ray attenuation
phenomenon [6]. Indeed, X-ray photons with lower energies
are preferentially attenuated and this inconsistency of X-ray
between different views results in misregistration of X-ray
attenuation producing false perfusion defect [6]. Recently
the dual energy computed tomography (DECT) has been
introduced to overcome this limitation [70]. This technique
simultaneously acquires 2 sets of projections using 2 different
X-ray energy spectra. In this way, DECT seems to be more
effective for correcting beam hardening artifacts due to
the ability to reconstruct monochromatic CCT images [71].
So far, based on technology available, two main kinds of
stress-CT can be performed. Static stress-CCT imaging is
usually preferred for scanner with low temporal resolution
and long scan time in which the myocardial perfusion is
reached from a single data sample acquired in arterial phase
timing. On the other side, the dynamic stress-CCT imaging,
usually performed with scanner with high temporal resolu-
tion and low scan time, is obtained from multiple samples
of myocardial attenuation at sequential time points after
contrast injection with a method similarly to the stress-CMR
previously described. For both approaches, the adenosine
infusion is usually used as stressor with the same protocol
described for stress-CMR. In Figure 6, the most common
protocol used in clinical practice is briefly described. Up
to now, a few single-centre studies [72–83] are available
regarding the diagnostic accuracy of stress-CCT and they are
summarized in Table 3 with a mean effective radiation dose
of rest plus stress scan of about 11mSv that is comparable with
the mean radiation exposure usually associated with SPECT
[51]. More recently, a multicenter trial CORE 320 [84] has
evaluated the diagnostic accuracy of stress-CCT as compared
to the combination of SPECTplus ICA.The results of this trial
showed in a patient-based model AUC of 0.87 for integrated
CCT and perfusion as compared to the algorithm SPECT
plus ICA. Figure 7 showed one case of stress-CCTwith single
source dual energy technique.
2.2.2. Fractional Flow Reserve by Cardiac Computed Tomog-
raphy (FFR-CT). In the “era” of FAME trial an emerging
BioMed Research International 9
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Figure 7: Clinical case of a 61-year-old man referred for suspected coronary artery disease. To rule out the presence of significant coronary
artery disease and ischemia, a rest-stress dual energy CCT has been performed. The exam showed a chronic total occlusion of the right
coronary artery (Panel (a) circle, Panel (b) arrow) due to a noncalcified plaque. The myocardial perfusion (Panel (c)) and iodine map (Panel
(d)) at rest do not show significant perfusion defect. Under stress condition (i.v. adenosine injection), dual energy computed tomography
showed a large perfusion defect in inferior wall of left ventricle (Panel (e) and (f), circle) with good matching as compared to stress cardiac
magnetic resonance (Panel (g), arrow). CCT: cardiac computed tomography.
interest has been increased on the possibility to measure in a
noninvasive setting the FFR. To this regard, software to deter-
mine FFR which computes the hemodynamic significance
of CAD from CCT dataset (FFR-CT) using computational
fluid dynamics under rest and simulated maximal coronary
hyperemic conditions has been recently developed [85].
Although the description of technical aspects of this method
is beyond the aim of this paper, the computation of FFR-CT
can be summarized as an integration of anatomic model of
coronary arteries derived by CCT plus a mathematical model
of coronary physiology including numerical solution of the
laws of physics governing fluid dynamics [85]. In otherwords,
the combination of high-resolution anatomic definition of
CAD via CCT with FFR-CT in a single test without the use
of stressors provides a noninvasive anatomic and functional
assessment of CAD in one-shot scan without the need of
additional functional test in case of obstructive CAD at CCT.
Results from 3 prospective multicenter trials have validated
the accuracy of FFR-CT as compared to invasive FFR [86–
88]. Koo et al. compared in DISCOVER-FLOW trial the
FFR-CT versus invasive FFR in 103 consecutive patients in a
vessel-based model showing diagnostic accuracy, sensitivity,
specificity, positive predictive value, and negative predictive
value of 84%, 88%, 82%, 74%, and 92%, respectively.The FFR-
CT increased the AUC from 0.75 for CCT alone up to 0.91
(𝑃: 0.001) and showed a good correlation with invasive FFR
(0.71, 𝑃 < 0.001). The main limitation of DISCOVER-FLOW
is that it was powered to evaluate the diagnostic accuracy in
a per-vessel model rather than per-patient model. The latter
point was evaluated in DE-FACTO trial [87] where, in larger
sample size of 252 patients, the FFR-CT showed diagnostic
accuracy, sensitivity, specificity, positive predictive value, and
negative predictive value of 73%, 90%, 54%, 67%, and 84%,
respectively, improving the AUC from 0.68 to 0.81 when
compared with CCT alone without functional evaluation.
More recently, the NXT trial [88] has demonstrated per-
patient sensitivity and specificity of 86% and 79%, respec-
tively, with AUC of 0.9 as compared to invasive FFR. Of note,
in patents with intermediate stenoses (the most common
setting of patients evaluated with noninvasive stress test)
the diagnostic performance of FFR-CT remained unchanged.
Differently for the two previous studies, the last generation
of FFR-CT software has been used, nitrates was employed
in 99% of study population against only 75% of DEFACTO
study population, and, last but not least, an intermediate risk
population was included rather than high-risk patients such
as the two previous studies. The main limitation of FFR-CT
remains still the not-negligible rate of not-evaluable patients
that reaches the 13% in the NXT-trial due to the poor image
quality. So far, the clinical validation of FFR-CT opens the
issue if the use of this software integrated to CCT dataset
is reasonable in terms of cost-effectiveness in intermediate
risk patients by “one-stop shop” offering coronary anatomy
and functional relevance of CAD. The final answer to this
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Figure 8: Clinical case of an intermediate risk patient symptomatic for chest pain. Panel (a) showed a multiplanar reconstruction of CCT
showing an obstructive stenosis of the middle right coronary artery (red circle) and computed fractional flow reserve (FFR-CT) value of 0.77,
indicating vessel ischemia (Panel (b)). Invasive coronary angiography confirmed the obstructive stenosis of the middle portion of the right
coronary artery (Panel (c), red circle) andmeasured fractional flow reserve (FFR) values of 0.76 (Panel (d), red circle). CCT: cardiac computed
tomography.
crucial question will arrive with the ongoing PLATFORM
trial (Prospective LongitudinAl Trial of FFRct: Outcome and
Resource IMpacts) that has the aim to compare the rate of
ICA documenting nonobstructive CAD, clinical outcomes,
quality of life, and resource utilization following standard
practice versus incorporating FFR-CT as the preferred test
to guide further noninvasive or invasive management and
medical treatment of patients. Figure 8 shows a clinical case of
patient in which FFR-CT has been performed and compared
to invasive FFR.
3. Conclusions
Theworld of cardiac imaging in the field of CAD is proposing
an increasing number of techniques with the aim to rule out
the presence of CAD and to identify the high-risk patients
who will benefit from expensive invasive procedures. There
is robust evidence that, to reach this aim, both coronary
anatomy and function need to be evaluated. How to obtain
combined anatomic and functional noninvasive imaging by
using one or multiple imaging modalities still has not been
demonstrated and it will be issue of debate for the next
years ensuring that “exciting times are ahead of cardiac
imagers.”
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